jubilant
-
Swift actions taken by Government to enhance availability of Remdesivir in India
Department of Pharmaceuticals intensified monitoring of availability, production and supply of drugs used for Covid-19 Treatment in early April, 2021…
Read More » -
Jubilant Pharmova’s subsidiary, Jubilant Pharma, announces the development of a novel oral formulation of Remdesivir with successful completion of safety and pharmacokinetic/absorption studies in animals and healthy human volunteers
India – April 19 2021 – Jubilant Pharma Limited, a subsidiary of Jubilant Pharmova Limited, announces successful completion of safety…
Read More » -
Entries open for the 12th edition of the prestigious ‘Social Entrepreneur of the Year (SEOY) – India Award 2021’
National, 12 April, 2021: Jubilant Bhartia Foundation and Schwab Foundation for Social Entrepreneurship, the sister organization of the World Economic…
Read More »